The head of the U.S. Food and Drug Administration is asking companies making sunscreen to conduct more research on the safety of products that protect against harmful sun rays. . . . → Read More: FDA Urges More Industry Sun Protection Research
|
|||||
A clinical trial shows treatments made with cannabidiol, a medical-grade derivative of cannabis plants, reduce the number of severe seizures in people with Lennox–Gastaut syndrome, when combined with conventional drugs. . . . → Read More: Cannabis Derivative Shown to Reduce Severe Seizures  Comments are closed  Regulations  biomedical, clinical trials, Europe, FDA, life sciences, pharmaceuticals, U.K., university 
Two companies developing therapies for inherited blood disorders say the Food and Drug Administration approved their application to begin clinical trials of treatments for sickle cell disease with gene editing. . . . → Read More: Clinical Trials Okayed for Sickle Cell Gene Editing One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, clinical trials, FDA, life sciences, pharmaceuticals, stem cells 
The Food and Drug Administration authorized a system for detecting diabetic retinopathy, a condition threatening the vision of people with diabetes, that uses artificial intelligence to analyze images of patients’ retinas. . . . → Read More: FDA Clears A.I. Software Detecting Diabetic Eye Disease Comments are closed Regulations biomedical, clinical trials, computer science, engineering, FDA, life sciences, mathematics, medical device, physical sciences, software, university A biotechnology enterprise developing gene therapies for rare inherited diseases and neurological disorders is being acquired by pharmaceutical company Novartis AG for $8.7 billion. . . . → Read More: Gene Therapy Biotech Acquired in $8.7 Billion Deal Comments are closed Finance biomedical, biotechnology, clinical trials, equity, Europe, FDA, genomics, investment, life sciences, merger, pharmaceuticals The Food and Drug Administration authorized a device that electronically monitors blood glucose levels in people with diabetes, but is also designed to exchange data with other compatible electronic systems. . . . → Read More: FDA Authorizes Interoperable Glucose Monitoring System Comments are closed Regulations biomedical, clinical trials, engineering, FDA, life sciences, medical device, software Follow-up reviews of results from direct-to-consumer genetic tests show 40 percent of the actionable gene variations reported in the tests, including some indicating disease risk, were erroneous. . . . → Read More: High False-Positive Rate Found in Consumer Genetic Tests One comment - (Comments are closed) Regulations biomedical, cancer, FDA, genomics, life sciences, medical device Initial results from two late-stage clinical trials show an experimental pain drug with non-opioid ingredients reduces the use of opioid pain relievers following surgery, compared to a placebo and standard care. . . . → Read More: Trials Show Pain Drug Reduces Post-Surgery Opioid Use One comment - (Comments are closed) Regulations biomedical, chemistry, clinical trials, FDA, life sciences, pharmaceuticals, physical sciences A technology that detects dangerous bacteria in patients’ blood samples in less than an hour received a breakthrough medical device designation from the U.S. Food and Drug Administration. . . . → Read More: Quick Bacterial Blood Detection Gains Breakthrough Tag One comment - (Comments are closed) New products, Regulations biomedical, engineering, entrepreneurs, FDA, life sciences, medical device, nanotechnology The Food and Drug Administration authorized the first direct-to-consumer tests of genetic risk for cancer, in this case 3 variations of genes associated with higher risk of breast and ovarian cancer. . . . → Read More: FDA Clears Consumer Genetic Breast Cancer Risk Tests Comments are closed Regulations biomedical, cancer, engineering, FDA, genomics, life sciences, medical device, software |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
